The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Redefining the Target: Chemotherapeutics as Antiangiogenics
Abstract
Angiogenesis, or new blood vessel formation, is now known to play an important role in both growth and metastasis of many cancers. The central importance of angiogenesis and the understanding of how new blood vessels are formed, has led to novel therapies designed to interrupt this process. Though specific antiangiogenic compounds have only recently entered the clinic, they herald a new era, one in which biology is the basis for therapy. The intense interest in angiogenesis has also lead to a re-examination of the activity of many established cytotoxic agents. Claims of antiangiogenic activity abound, unfortunately, with no common criteria and often little evidence of clinical relevance. What are we to think? Have oncologists unknowingly been administering antiangiogenic therapy all these years? If chemotherapeutics are really antiangiogenics in disguise, why have they failed to cure most solid tumors? Might the hard-learned lessons of chemotherapy resistance pertain to the novel antiangiogenics as well? Though we can offer no certain answers to these important questions, we do offer a framework on which to order the rapidly burgeoning literature. We suggest criteria by which a cytotoxic agent might reasonably be considered to have meaningful antiangiogenic activity. Finally, we describe potential mechanisms of resistance to antiangiogenic chemotherapies—some of which may apply to the pure antiangiogenics currently in development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
Gerber, H.-P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30336 · Cited by 1,981
Genes Expressed in Human Tumor Endothelium
Croix, B. S., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., et al. (2000) · Science · doi:10.1126/science.289.5482.1197 · Cited by 1,845
The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
Brown, J. M., & Giaccia, A. J. (1998) · PubMed · Cited by 1,748
Browder, T. D., Butterfield, C., Kräling, B. M., Shi, B., Marshall, B., OʼReilly, M., & Folkman, J. (2000) · PubMed · Cited by 1,543
Basement membrane complexes with biological activity
Kleinman, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. W., & Martin, G. R. (1986) · Biochemistry · doi:10.1021/bi00350a005 · Cited by 1,502
Ausprunk, D. H., & Folkman, J. (1977) · Microvascular Research · doi:10.1016/0026-2862(77)90141-8 · Cited by 1,281
Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., & Ellis, L. M. (1995) · PubMed · Cited by 1,265
Signaling Vascular Morphogenesis and Maintenance
Hanahan, D. (1997) · Science · doi:10.1126/science.277.5322.48 · Cited by 1,190
Folkman, J., & Haudenschild, C. (1980) · Nature · doi:10.1038/288551a0 · Cited by 1,037
Gerber, H.-P., Dixit, V., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13313 · Cited by 981
Eberhard, A., Kahlert, S., Goede, V., Hemmerlein, B., Plate, K. H., & Augustin, H. G. (2000) · PubMed · Cited by 873
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
Brooks, P. C., Strömblad, S., Klemke, R., Visscher, D., Sarkar, F. H., & Cheresh, D. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118227 · Cited by 828
Tumor Growth and Neovascularization: An Experimental Model Using the Rabbit Cornea 2
Gimbrone, M. A., Cotran, R. S., Leapman, S. B., & Folkman, J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/52.2.413 · Cited by 758
Holash, J., Wiegand, S. J., & Yancopoulos, G. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203035 · Cited by 744
Fràter-Schröder, M., Risau, W., Hallmann, R., Gautschi, P., & Böhlen, P. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5277 · Cited by 703
Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., & Ferrara, N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117857 · Cited by 694
Montesano, R., Orci, L., & Vassalli, P. (1983) · The Journal of cell biology · doi:10.1083/jcb.97.5.1648 · Cited by 647
The microtubule-affecting drug paclitaxel has antiangiogenic activity.
Belotti, D., Vergani, V., Drudis, T., Borsotti, P., Pitelli, M. R., Viale, G., Giavazzi, R., & Taraboletti, G. (1996) · PubMed · Cited by 643
Quantification of cells cultured on 96-well plates
Kueng, W., Silber, E., & Eppenberger, U. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90710-0 · Cited by 634
Vacca, A., Ribatti, D., Presta, M., Minischetti, M., Iurlaro, M., Ria, R., Albini, A., Bussolino, F., & Dammacco, F. (1999) · Blood · doi:10.1182/blood.v93.9.3064 · Cited by 599
Klauber, N., Parangi, S., Flynn, E. A., Hamel, E., & D’Amato, R. J. (1997) · PubMed · Cited by 524
Colleoni, M., Rocca, A., Sandri, M. T., Zorzino, L., Masci, G., Nolè, F., Peruzzotti, G., Robertson, C., Orlando, L., Cinieri, S., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf013 · Cited by 496
Microvessel density is a prognostic indicator for patients with astroglial brain tumors
Leon, S. P., Folkerth, R. D., & Black, P. M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2<362::aid-cncr20>3.0.co;2-z · Cited by 481
Using GFP in FRET-based applications
Pollok, B. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01434-2 · Cited by 480
Plate, K. H., Breier, G., Weich, H. A., Mennel, H. D., & Risau, W. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590415 · Cited by 463
Dvorak, H. F., Harvey, V. S., Estrella, P., Brown, L. F., McDonagh, J., & Dvořàk, A. M. (1987) · PubMed · Cited by 445
Tumor Angiogenesis: A Quantitative Method for Histologic Grading 2
(1972) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/48.2.347 · Cited by 414
Quantitative angiogenesis assays: Progress and problems
Jain, R. K., Schlenger, K., Hockel, M., & Yuan, F. (1997) · Nature Medicine · doi:10.1038/nm1197-1203 · Cited by 385
Gupta, K., Kshirsagar, S., Li, W., Gui, L., Ramakrishnan, S., Gupta, P., Law, P. Y., & Hebbel, R. P. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4359 · Cited by 379
A cancer therapy resistant to resistance
Kerbel, R. S. (1997) · Nature · doi:10.1038/36978 · Cited by 369
Sholley, M. M., Ferguson, G. P., Seibel, H. R., Montour, J. L., & Wilson, J. D. (1984) · PubMed · Cited by 366
Endothelial Nitric Oxide Synthase-Dependent Superoxide Generation from Adriamycin
Vásquez-Vivar, J., Martasek, P., Hogg, N., Masters, B. S. S., Pritchard, & Kalyanaraman, B. (1997) · Biochemistry · doi:10.1021/bi971475e · Cited by 366
INHIBITION OF CYCLOOXYGENASE-2 SUPPRESSES ANGIOGENESIS AND THE GROWTH OF PROSTATE CANCER IN VIVO
LIU, X. H., KIRSCHENBAUM, A., YAO, S., LEE, R., HOLLAND, J. F., & LEVINE, A. C. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67321-1 · Cited by 363
(1999) · PubMed · Cited by 348
Slaton, J. W., Perrotte, P., Inoue, K., Dinney, C. P., & Fidler, I. J. (1999) · PubMed · Cited by 337
Shaheen, R. M., Davis, D. W., Liu, W., Zebrowski, B. K., Wilson, M. R., Bucana, C. D., McConkey, D. J., McMahon, G., & Ellis, L. M. (1999) · PubMed · Cited by 334
Tran, J., Rak, J., Sheehan, C., Saibil, S. D., LaCasse, E., Korneluk, R. G., & Kerbel, R. S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1589 · Cited by 333
Paleolog, E. M., Young, S., Stark, A. C., McCloskey, R. V., Feldmann, M., & Maini, R. N. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1258::aid-art17>3.0.co;2-1 · Cited by 325
Mattern, J., Koomägi, R., & Volm, M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.166 · Cited by 309
(1968) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/41.1.111 · Cited by 283
Antiangiogenesis Is Produced by Nontoxic Doses of Vinblastine
Vacca, A., Iurlaro, M., Ribatti, D., Minischetti, M., Nico, B., Ria, R., Pellegrino, A., & Dammacco, F. (1999) · Blood · doi:10.1182/blood.v94.12.4143 · Cited by 279
Guidi, A. J., Abu-Jawdeh, G., Berse, B., Jackman, R. W., Tognazzi, K., Dvorak, H. F., & Brown, L. F. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.16.1237 · Cited by 276
Regina, A., Koman, A., Piciotti, M., El Hafny, B., Center, M. S., Bergmann, R., Couraud, P., & Roux, F. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020705.x · Cited by 266
Quantitation of Angiogenesis and Antiangiogenesis in the Chick Embryo Chorioallantoic Membrane
Nguyen, M., Shing, Y., & Folkman, J. (1994) · Microvascular Research · doi:10.1006/mvre.1994.1003 · Cited by 243
Fennelly, D., Aghajanian, C., Shapiro, F., O'Flaherty, C., McKenzie, M., O'Connor, C., Tong, W., Norton, L., & Spriggs, D. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.187 · Cited by 242
Dellian, M., Witwer, B. P., Salehi, H. A., Yuan, F., & Jain, R. K. (1996) · Europe PMC (PubMed Central) · Cited by 232
Larcher, F., Murillas, R., Bolontrade, M., Conti, C. J., & Jorcano, J. L. (1998) · Oncogene · doi:10.1038/sj.onc.1201928 · Cited by 231
Genetic heterogeneity of angiogenesis in mice
Rohan, R. M., Fernandez, A., Udagawa, T., Yuan, J., & D'Amato, R. J. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.871 · Cited by 214
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer.
Fox, S. B., Gatter, K. C., Bicknell, R., Going, J. J., Stanton, P. D., Cooke, T. G., & Harris, A. L. (1993) · PubMed · Cited by 210
Hirata, S., Matsubara, T., Saura, R., Hirohata, K., & Tateishi, H. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320903 · Cited by 201
Sandison, J. C. (1924) · The Anatomical Record · doi:10.1002/ar.1090280403 · Cited by 196
Bhushan, M., McLaughlin, B., Weiss, J. B., & Griffiths, C. E. M. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03205.x · Cited by 187
Albini, A. (1998) · Pathology & Oncology Research · doi:10.1007/bf02905254 · Cited by 183
Angiogenesis in the Mouse Cornea
Muthukkaruppan, V., & Auerbach, R. (1979) · Science · doi:10.1126/science.472760 · Cited by 182
Karsan, A., Yee, E., Poirier, G. G., Zhou, P., Craig, R. W., & Harlan, J. M. (1997) · Europe PMC (PubMed Central) · Cited by 180
An Adaptation of the Transparent-Chamber Technique to the Mouse
(1943) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/4.1.1 · Cited by 178
Gohongi, T., Fukumura, D., Boucher, Y., Yun, C., Soff, G. A., Compton, C. C., Todoroki, T., & Jain, R. K. (1999) · Nature Medicine · doi:10.1038/13524 · Cited by 144
Pesenti, E. A., Sola, F., Mongelli, N., Grandi, M., & Spreafico, F. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.272 · Cited by 118
Yonekura, K., Basaki, Y., Chikahisa, L., et al. (1999) · PubMed · Cited by 116
Tóth, K., Vaughan, M. M., Peress, N. S., Slocum, H. K., & Rustum, Y. M. (1996) · PubMed Central · Cited by 114
Antiangiogenic potential of camptothecin and topotecan
Clements, M. K., Jones, C. B., Cumming, M., & Daoud, S. S. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050997 · Cited by 114
Fukuda, S., Shirahama, T., Imazono, Y., Tsushima, T., Ohmori, H., Kayajima, T., Take, S., Nishiyama, K., Yonezawa, S., Akiba, S., et al. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990315)85:6<1323::aid-cncr15>3.0.co;2-g · Cited by 108
High-Time Chemotherapy or High Time for Low Dose
Kamen, B. A., Rubin, E., Aisner, J., & GLATSTEIN, E. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2935 · Cited by 104
O'Leary, J. J., Shapiro, R. L., Ren, C. J., Chuang, N., Cohen, H. W., & Potmĕsil, M. (1999) · PubMed · Cited by 96
Schirner, M., Hoffmann, J., Menrad, A., & Schneider, M. R. (1998) · PubMed · Cited by 95
Schlaifer, D., Laurent, G., Chittal, S. M., TSURUO, T., Souès, S., Muller, C., Charcosset, J., Alard, C., Brousset, P., & Mazerrolles, C. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.256 · Cited by 95
Angiogenesis-Regulating Cytokines: Activities and Interactions
Pepper, M. S., Mandriota, S. J., Vassalli, J. D., Orci, L., & Montesano, R. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-61109-4_3 · Cited by 84
An in vivo quantitative angiogenesis model using tumor cells entrapped in alginate.
Plunkett, M. L., & Hailey, J. A. (1990) · PubMed · Cited by 79
Endothelial injury caused by antineoplastic agents
Lazo, J. S. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90720-3 · Cited by 72
Tumor‐induced angiogenesis: Lack of inhibition by irradiation
Auerbach, R., ARENSMAN, R. M., Kubai, L., & Folkman, J. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910150209 · Cited by 72
Ghiso, N., Rohan, R. M., Amano, S., Garland, R., & Adamis, A. P. (1999) · PubMed · Cited by 71
A corneal micropocket assay for angiogenesis in the rat eye.
Fournier, G. A., Lutty, G. A., Watt, S., Fenselau, A. H., & Pätz, A. (1981) · PubMed · Cited by 69
Factors influencing blood supply in wound granuloma quantitated by a new in vivo technique.
Mahadevan, V., Hart, I. R., & Lewis, G. P. (1989) · PubMed · Cited by 59
Phthalocyanine Photodynamic Therapy of Experimental Iris Neovascularization
Miller, J. W., Stinson, W. G., Gregory, W. A., El-Koumy, H. A., & Puliafito, C. A. (1991) · Ophthalmology · doi:10.1016/s0161-6420(91)32079-7 · Cited by 58
Ocular Neovascularization With Retinal Vascular Occlusion
Virdi, P. S. (1982) · Archives of Ophthalmology · doi:10.1001/archopht.1982.01030030333024 · Cited by 55
Antiproliferative and angiostatic activity of suramin analogues.
Firsching-Hauck, A., Nickel, P., Mora, P., & Allolio, B. (1995) · PubMed · Cited by 50
Arsenault, A. L., Lhoták, Š., Hunter, W. L., Banquerigo, M. L., & Brahn, E. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4479 · Cited by 48
Inhibition of Angiogenesis by Anthracyclines and Titanocene Dichloridea
Maragoudakis, M. E., Peristeris, P., Missirlis, E., Aletras, A. J., Andriopoulou, P., & Haralabopoulos, G. C. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb24743.x · Cited by 46
Inhibition of angiogenesis by the antineoplastic agents mitoxantrone and bisantrene
Polverini, P. J., & NOVAK, R. F. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90720-5 · Cited by 42
Characterization and applications of the disc angiogenesis system
Kowalski, J., Kwan, H. H., Prionas, S. D., ALLISON, A. C., & Fajardo, L. F. (1992) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(92)90019-8 · Cited by 42
Ovarian cancer cell invasion is inhibited by paclitaxel
Westerlund, A., Hujanen, E., Höyhtyä, M., Puistola, U., & Turpeenniemi-Hujanen, T. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018481617275 · Cited by 37
Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells
Jones, C. B., Clements, M. K., Wasi, S., & Daoud, S. S. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050690 · Cited by 37
Effects of radiotherapy and estramustine on the microvasculature in malignant glioma
Johansson, M., Bergenheim, A. T., Widmark, A., & Henriksson, R. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690333 · Cited by 37
The preclinical evaluation of angiogenesis inhibitors
O’Reilly, M. S. (1997) · Investigational New Drugs · doi:10.1023/a:1005762410476 · Cited by 33
Suramin inhibits C6 glioma‐induced angiogenesis in vitro
Coomber, B. L. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240580209 · Cited by 30
Selective modulation of collagenase 1 gene expression by the chemotherapeutic agent doxorubicin.
Benbow, U., Maitra, R., Hamilton, J. W., & Brinckerhoff, C. (1999) · PubMed · Cited by 28
The Rat Subcutaneous Air Sac Model: A Quantitative Assay of Antiangiogenesis in Induced Vessels
Lichtenberg, J., Hjarnaa, P. V., Kristjansen, P. E. G., Hansen, D., & Binderup, L. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb02108.x · Cited by 11
Bassukas, I. D., Vester, G., & Maurer‐Schultze, B. (1990) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899411 · Cited by 9
Cited by
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Self-citationRole of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
Hicklin, D. J., & Ellis, L. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.081 · Cited by 3,007
The anti-angiogenic basis of metronomic chemotherapy
Kerbel, R. S., & Kamen, B. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1369 · Cited by 1,397
Cardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
Bracci, L., Schiavoni, G., Sistigu, A., & Belardelli, F. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.67 · Cited by 928
Metadata
- Authors
- Miller, K. D., Sweeney, C. J., & Sledge, G. W.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-02-15
- Volume
- 19
- Issue
- 4
- Pages
- 1195-1206
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2161714684
- Cited by
- 395
- References
- 93
- FWCI
- 10.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.